Kaiser Permanente Ventures is among the investors in an AI startup focused on medication management.
The venture capital arm of the Oakland, Calif.-based health system participated in a $30 million series C funding round June 24 for Arine. The company plans to use the funding to expand into specialty pharmacy management and advance AI automation, according to a news release.
Arine supports health plans and risk-bearing providers with a medication optimization platform for value-based care. Venture capital firm Town Hall Ventures led the funding round.
